SYK
Stryker Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Sell
-25/100
Last price
278.20
▼ 7.02 (2.46%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
285.19
Prev close
285.22
Day high
284.53
Day low
277.10
Volume
2.86M
Market cap
$106.71B
P/E (TTM)
29.56
52W range
267.00 – 392.55
Day trading desk
Gap from prior close
-0.01%
Prior close 285.22
VWAP
280.37
-0.77% from price
Relative volume
1.93×
Unusually busy
Session range
5.08%
272.99 – 286.85
Position in range
38%
Mid range
ATR (14D)
6.53
2.35% of price
Prior day high
286.09
PDH
Prior day low
275.00
PDL
Bid / ask spread
—
Quote not published
Session volume
5.08M
Avg 2.63M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.20%
-2.2%
1M
-8.22%
-9.4%
3M
-14.88%
-19.4%
6M
-16.22%
-34.4%
YTD
-20.85%
-35.1%
1Y
-24.91%
-41.3%
3Y
+1.80%
-80.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SYK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-642.66K
Net selling
Buy transactions
14
31.87K shares
Sell transactions
6
674.53K shares
Net transactions
+20
Buys less sells
Sell : buy shares
21.2 : 1
Heavily one-sided
Insider-held shares
20.57M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 21, 26 | CROTTY DYLAN BRAM Officer |
SELL | 441 | $144.91K | Indirect |
| Aug 19, 26 | STRYKER RONDA E Director |
SELL | 350.00K | $117.78M | Indirect |
| Aug 18, 26 | KING DEBRA Officer |
SELL | 826 | $277.79K | Direct |
| Jun 1, 26 | STILES SPENCER S President |
STOCK | 1.61K | $0 | Direct |
| May 28, 26 | FLETCHER ROBERT S Officer |
SELL | 4.54K | $1.39M | Direct |
| May 26, 26 | STRYKER RONDA E Director |
SELL | 310.00K | $96.79M | Indirect |
| May 11, 26 | FINK MARY KATHRYN Officer |
SELL | 8.72K | $2.47M | |
| May 8, 26 | FINK MARY KATHRYN Officer |
CONVERSION | 21.58K | $3.63M | Direct |
| May 6, 26 | SURI RAJEEV Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | SKEETE TATUM LISA M Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | CAFORIO GIOVANNI Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | RUGGERI RACHEL Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | MONTAGNINO KIMBERLY ANN Officer |
STOCK | 677 | $0 | Direct |
| May 6, 26 | MACEDA EMMANUEL PEREZ Director |
STOCK | 762 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BECKER YIN C |
Officer | 36.05K | Conversion of Exercise of derivative security |
CROTTY DYLAN BRAM |
Officer | — | Sale |
FINK MARY KATHRYN |
Officer | — | Sale |
GOLSTON ALLAN C |
Director | 14.89K | Sale |
LOBO KEVIN A |
Chief Executive Officer | 222.95K | Conversion of Exercise of derivative security |
MENON VIJU S |
Officer | 17.58K | Conversion of Exercise of derivative security |
PIERCE JAMES ANDREW |
Officer | 83.89K | Conversion of Exercise of derivative security |
SILVERNAIL ANDREW K. |
Director | 18.46K | Stock Award(Grant) |
STILES SPENCER S |
President | 77.72K | Stock Gift |
STRYKER RONDA E |
Director | — | Sale |
Fundamentals
Market cap$106.71B
Enterprise value$118.68B
Revenue (TTM)$25.84B
Gross profit$16.95B
EBITDA$7.38B
Net income$3.73B
EPS (TTM)$9.41
Free cash flow$4.11B
Total cash$3.48B
Total debt$15.45B
Book value / share$62.54
Shares outstanding383.57M
Float348.14M
Short % of float2.09%
Dividend yield1.23%
Beta (5Y)0.78
Valuation & profitability ratios
Trailing P/E29.56
Forward P/E16.65
PEG ratio1.34
Price / sales—
Price / book4.45
EV / revenue4.59
EV / EBITDA16.09
Gross margin65.59%
Operating margin27.02%
Profit margin14.43%
Return on equity16.51%
Return on assets8.16%
Debt / equity64.39
Current ratio2.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $25.12B | $22.59B | $20.50B | $18.45B | +11.2% |
| Operating revenue | $25.12B | $22.59B | $20.50B | $18.45B | +11.2% |
| Cost of revenue | $9.05B | $8.15B | $7.44B | $6.87B | +11.0% |
| Gross profit | $16.07B | $14.44B | $13.06B | $11.58B | +11.3% |
| Research & development | $1.62B | $1.47B | $1.39B | $1.45B | +10.7% |
| Selling, general & admin | $8.65B | $7.68B | $7.11B | $6.39B | +12.6% |
| Total operating expense | $11.01B | $9.77B | $9.13B | $8.47B | +12.6% |
| Operating income | $5.06B | $4.67B | $3.92B | $3.11B | +8.4% |
| Net interest income | -$607.00M | -$409.00M | -$363.00M | — | -48.4% |
| Pre-tax income | $4.51B | $3.49B | $3.67B | $2.68B | +29.3% |
| Tax provision | $1.27B | $499.00M | $508.00M | $325.00M | +154.1% |
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | +8.5% |
| Net income to common | $3.25B | $2.99B | $3.17B | $2.36B | +8.5% |
| Basic EPS | 8.49 | 7.86 | 8.34 | 6.23 | +8.0% |
| Diluted EPS | 8.40 | 7.76 | 8.25 | 6.17 | +8.2% |
| EBIT | $5.12B | $3.90B | $4.04B | $3.11B | +31.3% |
| EBITDA | $6.31B | $4.95B | $5.06B | $4.11B | +27.5% |
| Basic shares | 382.20M | 381.00M | 379.60M | 378.20M | +0.3% |
| Diluted shares | 386.50M | 385.60M | 383.70M | 382.20M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.01B | $3.65B | $2.97B | $1.84B | +9.8% |
| Cash & short-term investments | $4.10B | $4.49B | $3.05B | $1.93B | -8.7% |
| Accounts receivable | $4.04B | $3.99B | $3.77B | $3.56B | +1.3% |
| Inventory | $5.31B | $4.77B | $4.84B | $4.00B | +11.2% |
| Total current assets | $14.76B | $14.85B | $12.52B | $10.28B | -0.6% |
| Property, plant & equipment | $3.88B | $3.45B | $3.21B | $2.97B | +12.4% |
| Goodwill & intangibles | $24.97B | $20.25B | $19.84B | $19.77B | +23.3% |
| Total assets | $47.84B | $42.97B | $39.91B | $36.88B | +11.3% |
| Total current liabilities | $7.79B | $7.62B | $7.92B | $6.30B | +2.3% |
| Current debt | $1.00B | $1.41B | $2.09B | $1.19B | -29.0% |
| Long-term debt | $14.86B | $12.19B | $10.90B | $11.86B | +21.9% |
| Total debt | $15.86B | $13.60B | $12.99B | $13.05B | +16.6% |
| Total liabilities | $25.42B | $22.34B | $21.32B | $20.27B | +13.8% |
| Retained earnings | $20.47B | $18.53B | $16.77B | $14.77B | +10.5% |
| Shareholder equity | $22.42B | $20.63B | $18.59B | $16.62B | +8.7% |
| Working capital | $6.96B | $7.23B | $4.60B | $3.97B | -3.7% |
| Net tangible assets | -$2.55B | $384.00M | -$1.24B | -$3.15B | -764.6% |
| Shares issued | 382.50M | 381.40M | 380.10M | 378.70M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | — | +8.5% |
| Depreciation & amortisation | $1.19B | $1.05B | $1.03B | $998.00M | — | +13.6% |
| Stock-based compensation | $243.00M | $229.00M | $205.00M | $168.00M | — | +6.1% |
| Change in working capital | -$373.00M | -$683.00M | -$517.00M | -$1.24B | — | +45.4% |
| Operating cash flow | $5.04B | $4.24B | $3.71B | $2.62B | — | +18.9% |
| Capital expenditure | -$761.00M | -$755.00M | -$575.00M | -$588.00M | — | -0.8% |
| Investing cash flow | -$4.87B | -$3.00B | -$962.00M | -$2.92B | — | -62.2% |
| Share buybacks | — | — | — | — | $0 | — |
| Dividends paid | -$1.28B | -$1.22B | -$1.14B | -$1.05B | — | -5.3% |
| Financing cash flow | $113.00M | -$525.00M | -$1.59B | -$749.00M | — | +121.5% |
| Free cash flow | $4.28B | $3.49B | $3.14B | $2.04B | — | +22.8% |
| End cash position | $4.01B | $3.65B | $2.97B | $1.84B | — | +9.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $6.59B | $6.02B | $7.17B | $6.06B | $6.02B | — | +9.5% |
| Operating revenue | $6.59B | $6.02B | $7.17B | $6.06B | $6.02B | — | +9.5% |
| Cost of revenue | $2.09B | $2.21B | $2.54B | $2.21B | $2.18B | — | -5.4% |
| Gross profit | $4.50B | $3.81B | $4.63B | $3.85B | $3.84B | — | +18.1% |
| Research & development | $434.00M | $413.00M | $401.00M | $410.00M | $407.00M | — | +5.1% |
| Selling, general & admin | $2.23B | $2.28B | $2.23B | $2.04B | $2.08B | — | -2.3% |
| Total operating expense | $2.84B | $2.87B | $2.82B | $2.64B | $2.67B | — | -1.3% |
| Operating income | $1.66B | $936.00M | $1.81B | $1.21B | $1.17B | — | +77.4% |
| Net interest income | -$141.00M | -$148.00M | — | — | -$159.00M | -$137.00M | +4.7% |
| Pre-tax income | $1.56B | $850.00M | $1.71B | $1.03B | $1.02B | — | +84.0% |
| Tax provision | $288.00M | $105.00M | $856.00M | $170.00M | $132.00M | — | +174.3% |
| Net income | $1.28B | $745.00M | $849.00M | $859.00M | $884.00M | — | +71.3% |
| Net income to common | $1.28B | $745.00M | $849.00M | $859.00M | $884.00M | — | +71.3% |
| Basic EPS | 3.32 | 1.95 | 2.21 | 2.25 | 2.32 | — | +70.3% |
| Diluted EPS | 3.30 | 1.93 | 2.20 | 2.22 | 2.29 | — | +71.0% |
| EBIT | $1.71B | $998.00M | $1.87B | $1.21B | $1.18B | — | +70.8% |
| EBITDA | $2.00B | $1.30B | $2.19B | $1.52B | $1.47B | — | +54.2% |
| Basic shares | 383.50M | 382.90M | 382.50M | 382.40M | 382.20M | — | +0.2% |
| Diluted shares | 386.00M | 386.50M | 386.50M | 386.70M | 386.40M | — | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.39B | $2.88B | $4.01B | $3.26B | $2.38B | +17.8% |
| Cash & short-term investments | $3.48B | $2.96B | $4.10B | $3.34B | $2.46B | +17.2% |
| Accounts receivable | $3.74B | $3.57B | $4.04B | $3.64B | $3.92B | +4.8% |
| Inventory | $5.52B | $5.42B | $5.31B | $5.37B | $5.29B | +1.9% |
| Total current assets | $14.42B | $13.34B | $14.76B | $13.71B | $13.00B | +8.1% |
| Property, plant & equipment | $3.96B | $3.89B | $3.88B | $3.73B | $3.70B | +1.8% |
| Goodwill & intangibles | $25.33B | $24.70B | $24.97B | $25.10B | $25.14B | +2.5% |
| Total assets | $47.93B | $46.29B | $47.84B | $47.06B | $46.33B | +3.5% |
| Total current liabilities | $6.68B | $6.32B | $7.79B | $7.41B | $7.29B | +5.8% |
| Current debt | $750.00M | $499.00M | $1.00B | $1.75B | $1.75B | +50.3% |
| Long-term debt | $14.19B | $14.22B | $14.86B | $14.85B | $14.83B | -0.2% |
| Total debt | $14.94B | $14.72B | $15.86B | $16.59B | $16.58B | +1.5% |
| Total liabilities | $23.94B | $23.31B | $25.42B | $25.27B | $25.14B | +2.7% |
| Retained earnings | $21.82B | $20.88B | $20.47B | $19.96B | $19.42B | +4.5% |
| Shareholder equity | $23.99B | $22.98B | $22.42B | $21.79B | $21.19B | +4.4% |
| Working capital | $7.73B | $7.02B | $6.96B | $6.30B | $5.71B | +10.1% |
| Net tangible assets | -$1.34B | -$1.73B | -$2.55B | -$3.32B | -$3.95B | +22.4% |
| Shares issued | 383.57M | 383.36M | 382.50M | 382.42M | 382.31M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.28B | $745.00M | $849.00M | $859.00M | $884.00M | +71.3% |
| Depreciation & amortisation | $296.00M | $300.00M | $316.00M | $309.00M | $296.00M | -1.3% |
| Stock-based compensation | $54.00M | $87.00M | $48.00M | $62.00M | $49.00M | -37.9% |
| Change in working capital | -$431.00M | -$560.00M | $709.00M | $161.00M | -$351.00M | +23.0% |
| Operating cash flow | $1.26B | $581.00M | $2.14B | $1.54B | $1.11B | +117.0% |
| Capital expenditure | -$202.00M | -$166.00M | -$268.00M | -$187.00M | -$183.00M | -21.7% |
| Investing cash flow | -$639.00M | -$185.00M | -$305.00M | -$321.00M | -$104.00M | -245.4% |
| Dividends paid | -$337.00M | -$337.00M | -$321.00M | -$322.00M | -$321.00M | 0.0% |
| Financing cash flow | -$95.00M | -$1.51B | -$1.09B | -$339.00M | -$989.00M | +93.7% |
| Free cash flow | $1.06B | $415.00M | $1.88B | $1.35B | $928.00M | +155.2% |
| End cash position | $3.39B | $2.88B | $4.01B | $3.26B | $2.38B | +17.8% |
Options analytics
Put / call volume
6.89
Put-heavy session
Put / call open interest
0.42
Positioning, not flow
Max pain
280.00
+0.6% from spot
ATM implied vol
37.2%
Nearest strike to spot
Skew (10% OTM)
-0.4%
Calls bid over puts
Call volume
236
Contracts, this expiry
Put volume
1.63K
Contracts, this expiry
Heaviest call OI
280.00
805 contracts
Heaviest put OI
270.00
460 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 3.49 | 3.69 | +5.8% |
| Mar 2026 | 2.98 | 2.60 | -12.9% |
| Dec 2025 | 4.40 | 4.47 | +1.7% |
| Sep 2025 | 3.13 | 3.19 | +1.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 3.56 | 24 | $6.63B | +9.5% |
| Next quarter | 5.13 | 23 | $7.97B | +11.2% |
| Current year | 14.98 | 27 | $27.21B | +8.4% |
| Next year | 16.70 | 27 | $29.57B | +8.6% |
Analyst targets & ownership
Mean target$365.80
High target$465.00
Low target$298.00
Implied upside31.49%
Analyst count25
ConsensusBUY
Strong buy / Buy7 / 15
Hold6
Sell / Strong sell0 / 0
Held by insiders5.36%
Held by institutions82.77%
Institutions holding3.03K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
275.68
+0.91% from price
SMA 20
276.52
+0.61% from price
SMA 50
309.14
-10.01% from price
SMA 100
311.87
-10.80% from price
SMA 200
329.50
-15.57% from price
EMA 12
278.28
-0.03% from price
EMA 26
286.35
-2.85% from price
EMA 50
297.97
-6.64% from price
RSI (14)
42.7
Neutral
MACD (12,26,9)
-8.07
Hist 2.47
ATR (14)
6.53
2.35% of price
Realised vol 30D
35.8%
Annualised
Bollinger upper
285.02
20, 2σ
Bollinger lower
268.02
20, 2σ
50 / 200 cross
Death
309.14 vs 329.50
Trend bias
Below 200
-15.57%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.16
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
35.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-30.5%
Peak to trough
Max drawdown 5Y
-33.2%
Peak to trough
ATR 14
6.53
2.35% of price
Beta (reported)
0.78
5Y monthly, from filing
Short interest
Shares short
7.67M
Prior 6.94M
Change vs prior
+10.5%
Shorts adding
% of float
2.09%
Normal
% of shares out
2.00%
Against total outstanding
Days to cover
2.7
Liquid
Float
348.14M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | Stifel | MAINTAINED | Buy | Buy |
| Sep 22, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Sep 18, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Sep 10, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Sep 9, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 13, 26 | Wolfe Research | DOWNGRADE | Outperform | Peer Perform |
| Aug 3, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jul 31, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 31, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jul 31, 26 | BTIG | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate$3.52 / yr
Forward yield1.23%
5-year avg yield0.99%
Payout ratio36.06%
Ex-dividend dateSep 30, 2026
Next pay dateOct 30, 2026
Last split2:1
Split dateMay 17, 2004
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-06
Periodic Financial Reports
10-Q · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-06-26
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-22
Corporate Changes & Voting Matters
8-K · 2026-05-20
Periodic Financial Reports
10-Q · 2026-05-11
Corporate Changes & Voting Matters
8-K · 2026-05-08
Headlines
Stryker (SYK) vs Boston Scientific (BSX): Which is a Better Stock to Buy?
Insider Monkey · 4h ago
Stryker, Neogenomics Announce CEO Transitions; Both Stocks Dive
Investor's Business Daily · 7h ago
Sector Update: Healthcare Stocks Mixed Late Afternoon
MT Newswires · 8h ago
Stryker Stock In Focus As Truist Says CEO Transition Is Low-Risk, Cuts Price Target To $310
Stocktwits · 10h ago
Sector Update: Healthcare Stocks Mixed Tuesday Afternoon
MT Newswires · 10h ago
Truist Securities Cuts Stryker Price Target to $310 From $340, Maintains Hold Rating
MT Newswires · 11h ago
Stryker CEO Kevin Lobo to resign
MedTech Dive · 12h ago
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
Zacks · 13h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.